Keywords: myotrophin, nda, filed, usa, cephalon, chiron, approval

Myotrophin NDA Filed In The USA

Article | 17 February 1997

Print This

Cephalon and Chiron have filed for approval of Myotrophin (mecasermin;insulin-like growth factor-1) in the USA for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in